VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR)
CUSIP: 929033108
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 64,806,628
- Total 13F shares
- 60,090,600
- Share change
- -855,873
- Total reported value
- $43,114,461
- Price per share
- $0.72
- Number of holders
- 44
- Value change
- -$1,211,908
- Number of buys
- 18
- Number of sells
- 33
Quarterly Holders Quick Answers
What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 929033108:
Top shareholders of VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
61%
|
39,646,039
|
$44,007,103 | — | 31 Dec 2024 | |
| FMR LLC |
13F
|
Company |
9.9%
|
6,419,633
|
$7,125,792 | — | 31 Dec 2024 | |
| 5AM Venture Management, LLC |
13F
|
Company |
9.8%
|
6,361,723
|
$7,061,513 | — | 31 Dec 2024 | |
| 5AM Ventures VI, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,766,634
|
$3,215,274 | — | 16 Nov 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
1,942,821
|
$2,156,531 | — | 31 Dec 2024 | |
| JOHNSON & JOHNSON |
13F
|
Company |
1.7%
|
1,074,658
|
$1,192,870 | — | 31 Dec 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
0.98%
|
637,218
|
$707,312 | — | 31 Dec 2024 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.95%
|
618,000
|
$685,980 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.82%
|
529,500
|
$587,745 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.75%
|
488,363
|
$542,083 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.65%
|
422,143
|
$468,712 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.51%
|
329,378
|
$365,610 | — | 31 Dec 2024 | |
| Nathan D. Jorgensen |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
mixed-class rows
|
289,403
mixed-class rows
|
$331,455 | — | 06 May 2024 | |
| MAI Capital Management |
13F
|
Company |
0.44%
|
283,199
|
$314,351 | — | 31 Dec 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
261,837
|
$290,639 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.31%
|
200,405
|
$222,450 | — | 31 Dec 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.26%
|
165,805
|
$184,044 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.25%
|
163,064
|
$181,001 | — | 31 Dec 2024 | |
| Eyal C. Attar |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
441,625
mixed-class rows
|
$179,808 | — | 13 Feb 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
159,910
|
$177,500 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
157,617
|
$174,955 | — | 31 Dec 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
132,600
|
$147,186 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.18%
|
115,934
|
$128,687 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.18%
|
115,028
|
$127,681 | — | 31 Dec 2024 | |
| Trustees of Columbia University in the City of New York |
13F
|
Company |
0.14%
|
91,910
|
$102,020 | — | 31 Dec 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.13%
|
86,685
|
$95,000 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.11%
|
71,788
|
$79,685 | — | 31 Dec 2024 | |
| Bollard Group LLC |
13F
|
Company |
0.09%
|
55,555
|
$62,000 | — | 31 Dec 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.08%
|
54,470
|
$60,000 | — | 31 Dec 2024 | |
| LMR Partners LLP |
13F
|
Company |
0.08%
|
51,111
|
$56,733 | — | 31 Dec 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.07%
|
44,728
|
$48,754 | — | 31 Dec 2024 | |
| Amy Quinlan |
3/4/5
|
Vice President of Finance |
—
class O/S missing
|
50,312
|
$43,268 | — | 06 Nov 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.06%
|
37,190
|
$41,281 | — | 31 Dec 2024 | |
| GABELLI & Co INVESTMENT ADVISERS, INC. |
13F
|
Company |
0.05%
|
30,000
|
$33,300 | — | 31 Dec 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.04%
|
28,090
|
$31,180 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
27,500
|
$30,525 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
26,698
|
$29,635 | — | 31 Dec 2024 | |
| MONEY CONCEPTS CAPITAL CORP |
13F
|
Company |
0.04%
|
25,000
|
$27,750 | — | 31 Dec 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.02%
|
16,102
|
$17,873 | — | 31 Dec 2024 | |
| UNITED BANK |
13F
|
Company |
0.02%
|
15,300
|
$16,983 | — | 31 Dec 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.02%
|
11,024
|
$12,237 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
10,667
|
$11,840 | — | 31 Dec 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
10,069
|
$11,177 | — | 31 Dec 2024 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.02%
|
10,000
|
$11,000 | — | 31 Dec 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
4,569
|
$5,000 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,601
|
$3,997 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
3,045
|
$3,380 | — | 31 Dec 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
2,422
|
$2,688 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,393
|
$2,656 | — | 31 Dec 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,149
|
$1,275 | — | 31 Dec 2024 |
Institutional Holders of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) as of Q1 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.